HCPCS Level II › J

HCPCS Level II codes starting with J

1,255 codes, page 2 of 13. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
J0480 Injection, basiliximab, 20 mg Valid
J0485 Injection, belatacept, 1 mg Valid
J0490 Injection, belimumab, 10 mg Valid
J0491 Injection, anifrolumab-fnia, 1 mg Valid
J0500 Injection, dicyclomine hcl, up to 20 mg Valid
J0515 Injection, benztropine mesylate, per 1 mg Valid
J0517 Injection, benralizumab, 1 mg Valid
J0520 Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg Valid
J0525 Injection, cefotetan disodium, 10 mg Valid
J0528 Injection, fosfomycin disodium, 20 mg Valid
J0558 Injection, penicillin g benzathine and penicillin g procaine, 100,000 units Valid
J0561 Injection, penicillin g benzathine, 100,000 units Valid
J0565 Injection, bezlotoxumab, 10 mg Valid
J0567 Injection, cerliponase alfa, 1 mg Valid
J0570 Buprenorphine implant, 74.2 mg Valid
J0571 Buprenorphine, oral, 1 mg Valid
J0572 Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine Valid
J0573 Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine Valid
J0574 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine Valid
J0575 Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine Valid
J0576 Injection, buprenorphine extended-release (brixadi), 1 mg through FY2026 Terminated
J0577 Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy Valid
J0578 Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy Valid
J0582 Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg Valid
J0583 Injection, bivalirudin, 1 mg Valid
J0584 Injection, burosumab-twza 1 mg Valid
J0585 Injection, onabotulinumtoxina, 1 unit Valid
J0586 Injection, abobotulinumtoxina, 5 units Valid
J0587 Injection, rimabotulinumtoxinb, 100 units Valid
J0588 Injection, incobotulinumtoxin a, 1 unit Valid
J0589 Injection, daxibotulinumtoxina-lanm, 1 unit Valid
J0591 Injection, deoxycholic acid, 1 mg Valid
J0592 Injection, buprenorphine hydrochloride, 0.1 mg Valid
J0593 Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered) Valid
J0594 injection, busulfan, 1 mg Valid
J0595 Injection, butorphanol tartrate, 1 mg Valid
J0596 Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units Valid
J0597 Injection, c-1 esterase inhibitor (human), berinert, 10 units Valid
J0598 Injection, c-1 esterase inhibitor (human), cinryze, 10 units Valid
J0599 Injection, c-1 esterase inhibitor (human), (haegarda), 10 units Valid
J0600 Injection, edetate calcium disodium, up to 1000 mg Valid
J0601 Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis) Valid
J0602 Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis) Valid
J0603 Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis) Valid
J0604 Cinacalcet, oral, 1 mg, (for esrd on dialysis) Valid
J0605 Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis) Valid
J0606 Injection, etelcalcetide, 0.1 mg Valid
J0607 Lanthanum carbonate, oral, 5 mg (for esrd on dialysis) Valid
J0608 Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis) Valid
J0609 Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis) Valid
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml through FY2026 Terminated
J0611 Injection, calcium gluconate (wg critical care), per 10 ml through FY2026 Terminated
J0612 Injection, calcium gluconate, not otherwise specified, 10 mg Valid
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg Valid
J0614 Injection, treosulfan, 50 mg Valid
J0615 Calcium acetate, oral, 23 mg (for esrd on dialysis) Valid
J0616 Injection, metoprolol tartrate, 1 mg Valid
J0618 Injection, calcium chloride, 2 mg Valid
J0620 Injection, calcium glycerophosphate and calcium lactate, per 10 ml Valid
J0630 Injection, calcitonin salmon, up to 400 units Valid
J0636 Injection, calcitriol, 0.1 mcg Valid
J0637 Injection, caspofungin acetate, 5 mg Valid
J0638 Injection, canakinumab, 1 mg Valid
J0640 Injection, leucovorin calcium, per 50 mg through FY2026 Terminated
J0641 Injection, levoleucovorin, not otherwise specified, 0.5 mg Valid
J0642 Injection, levoleucovorin (khapzory), 0.5 mg Valid
J0643 Injection, leucovorin calcium, not otherwise specified, 1 mg Valid
J0644 Injection, leucovorin calcium (avyxa), 1 mg Valid
J0650 Injection, levothyroxine sodium, not otherwise specified, 10 mcg Valid
J0651 Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg Valid
J0652 Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg Valid
J0654 Injection, liothyronine, 1 mcg Valid
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg Valid
J0666 Injection, bupivacaine liposome, 1 mg Valid
J0668 Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg Valid
J0670 Injection, mepivacaine hydrochloride, per 10 ml Valid
J0675 Injection, carboprost tromethamine, 0.1 mg Valid
J0681 Injection, ceftobiprole medocaril sodium, 3 mg Valid
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg Valid
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg Valid
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg Valid
J0690 Injection, cefazolin sodium, 500 mg Valid
J0691 Injection, lefamulin, 1 mg Valid
J0692 Injection, cefepime hydrochloride, 500 mg Valid
J0693 Injection, cefiderocol, 5 mg through FY2026 Terminated
J0694 Injection, cefoxitin sodium, 1 gm Valid
J0695 Injection, ceftolozane 50 mg and tazobactam 25 mg Valid
J0696 Injection, ceftriaxone sodium, per 250 mg Valid
J0697 Injection, sterile cefuroxime sodium, per 750 mg Valid
J0698 Injection, cefotaxime sodium, per gm Valid
J0699 Injection, cefiderocol, 10 mg Valid
J0701 Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg Valid
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Valid
J0703 Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg Valid
J0706 Injection, caffeine citrate, 5 mg Valid
J0710 Injection, cephapirin sodium, up to 1 gm through FY2026 Terminated
J0712 Injection, ceftaroline fosamil, 10 mg Valid
J0713 Injection, ceftazidime, per 500 mg Valid
J0714 Injection, ceftazidime and avibactam, 0.5 g/0.125 g Valid
J0715 Injection, ceftizoxime sodium, per 500 mg through FY2026 Terminated
Page 2 of 13